Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Medtronic
Colorcon
Boehringer Ingelheim
Dow

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lysergic Acid Diethylamide

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Lysergic Acid Diethylamide?

Lysergic Acid Diethylamide is an investigational drug.

There have been 11 clinical trials for Lysergic Acid Diethylamide. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2017.

The most common disease conditions in clinical trials are Anxiety Disorders, Headache, and Cluster Headache. The leading clinical trial sponsors are University Hospital, Basel, Switzerland, Matthias Liechti, and Psychiatric University Hospital, Zurich.

There are six hundred and twenty-seven US patents protecting this investigational drug and four international patents.

Recent Clinical Trials for Lysergic Acid Diethylamide
TitleSponsorPhase
LSD Therapy for Persons Suffering From Major DepressionDepartment of Psychiatry Basel (UPK Basel; Prof. Dr. med. Stefan Borgwardt)Phase 2
LSD Therapy for Persons Suffering From Major DepressionUniversity Hospital, Basel, SwitzerlandPhase 2
Lysergic Acid Diethylamide (LSD) as Treatment for Cluster HeadacheUniversity Hospital, Basel, SwitzerlandPhase 2

See all Lysergic Acid Diethylamide clinical trials

Clinical Trial Summary for Lysergic Acid Diethylamide

Top disease conditions for Lysergic Acid Diethylamide
Top clinical trial sponsors for Lysergic Acid Diethylamide

See all Lysergic Acid Diethylamide clinical trials

US Patents for Lysergic Acid Diethylamide

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Lysergic Acid Diethylamide   Start Trial Tamper-resistant pharmaceutical compositions of opioids and other drugs COLLEGIUM PHARMACEUTICAL, INC. (Canton, MA)   Start Trial
Lysergic Acid Diethylamide   Start Trial Biomarkers in inflammatory bowel disease UNIVERSITY OF TROMSO (Tromso, NO)   Start Trial
Lysergic Acid Diethylamide   Start Trial Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC)   Start Trial
Lysergic Acid Diethylamide   Start Trial Pharmaceutical compositions for treating or preventing pain LOCL PHARMA, INC. (Las Vegas, NV)   Start Trial
Lysergic Acid Diethylamide   Start Trial Methods for treatment or prevention of damage resulting from radiation, trauma or shock SYNEDGEN, INC. (Claremont, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Lysergic Acid Diethylamide

Drugname Country Document Number Estimated Expiration Related US Patent
Lysergic Acid Diethylamide Australia 2003247876 2022-07-05   Start Trial
Lysergic Acid Diethylamide Canada 2491572 2022-07-05   Start Trial
Lysergic Acid Diethylamide Canada 2569958 2022-07-05   Start Trial
Lysergic Acid Diethylamide Canada 2916869 2022-07-05   Start Trial
Lysergic Acid Diethylamide Cyprus 1119831 2022-07-05   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Moodys
Johnson and Johnson
Express Scripts
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.